CALL US: 1-855-483-4325

High Dose Conditioning with Ifosfamide, Carboplatin and Etoposide with Autologous Stem Cell Transplantation for Patients with recurrent Nasopharyngeal Carcinoma

Purpose

1. To evaluate the response rates for patients undergoing high dose conditioning using Etoposide, Carboplatin and Ifsofamide followed by autologous stem cell transplantation for the treatment of recurrent NPC in children, adolescents, and young adults. 2. To evaluate the toxicities associated with undergoing high dose conditioning using Etoposide, Carboplatin and Ifsofamide followed by autologous stem cell transplantation for the treatment of recurrent NPC in children, adolescents, and young adults.

Keywords

Autologous, Stem Cell Transplantation, recurrent, Nasopharyngeal, Carcinoma

Principal Investigator

Lamis Eldjerou, M.D.

Department

PEDIATRIC HEMATOLOGY

Contact Information

leldjerou@peds.ufl.edu
3522739120

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams